ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,201.60
1.67%
S&P ASX All Technology
3,829.30
1.67%
Brent Oil
72.805
0.12%
US Dollar vs AUD
1.59898
-0.03%
Bitcoin
95,258.00
0.16%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NeuroSense Therapeutics Ltd (NRSN)

  7. NeuroSense Therapeutics Ltd (NRSN) News

NeuroSense Therapeutics Ltd

NeuroSense Therapeutics Ltd (NRSN)

NASDAQ
1.36
0.08
(6.25%)
Closed 23 December 8:00AM
Delayed by 15 minutes
1.3799
0.0199
(1.46%)
After Hours: 11:29AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

NRSN News

Official News Only

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
31 August 2024
NRSN (6.25%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
28 August 2024
NRSN (6.25%)

NRSN Discussion

View Posts
johnhancoque johnhancoque 3 days ago
Nobody claims a multibillion dollar partnership. Read the headlines. They are in discussions with several multi- billion dollar companies for partnerships. Also, they could have done a large public offering to keep the lights on as they are nasdaq listed. Instead the ceo chose to do a private placement and buy 5 million worth. The partnerships are for funding the continued trials and I know alot about how things work with pharma as I've been trading bios 20 years. The data is impressive and worth Billions and as the market catches on expect significant rises in the share price
👍️0
runncoach runncoach 3 days ago
How much do you think a P3 cost? That's why so little leverage. Why didn't they already get a partnership they've talked about for 4 months? It's not easy when you don't have cash. It's not going to be a multi billion partnership that I've seen some posting about. Ceo kept them listed and gave a couple months breathing room. Congrats to him
👍️0
johnhancoque johnhancoque 3 days ago
Right. You believe he did it to keep the lights on when he could have done a public offering for alot more. Instead, he spent 5 million of his own money suggesting he has faith in a very large partnership. Your way of thinking is twisted. No need reply again
👍️0
runncoach runncoach 3 days ago
I'm suggesting he bought to keep the company's listing and float the company til they find funding since they can't fund a P3 trial. It's not a strong position to negotiate from. I don't think I'm saying anything controversial or that isn't common sense at this point. I expect them to find something and then there will be a very long wait
👍️0
johnhancoque johnhancoque 3 days ago
You're suggesting the ceo bought 5 million worth of stock this month well above market value because he may not succeed in finding a partner? That sounds ridiculous buddy. It's more likely he is very confident in finding a partnership or is in the final stages so he bought 5 million worth. Your understanding of how insiders buys shares is out to bloody lunch. Hardly anyone would spend 5 million on a single stock without a near sure bet let alone a ceo of a publicly traded company
👍️0
johnhancoque johnhancoque 3 days ago
A ceo who had no faith in a partnership sure as he'll wouldn't pony up 5 million bucks if there was nothing in the works. Don't miss the forest for the trees. He bought 5 million worth because a partnership is in the works.
Smh
👍️0
runncoach runncoach 3 days ago
Been here long before you. Ceo ponied up money to meet Nasdaq requirements. Stock got shorted down so the "raise" price would look better.

Doesn't take a genius to realize not having the cash to even make it to the start of launching a P3 next summer isn't negotiating from a position of strength. If they don't get a partnership there would have to be a very unfavorable money raise to launch the trial. Between a rock and a hard place as far as negotiating.

Let's hope they get a partnership on favorable terms and a nice spike before the stock pulls back with the markets realizing another 12+ months til Canadian news and much longer than that for US.
👍️0
johnhancoque johnhancoque 3 days ago
So now and ceo who buys 5 million worth of stock isn't a good sign, it's a bad sign of a pump? Where do you guys come from, really?
Even with good news you shorts twist things unrecognizable. Truly unbelievable
The ceo bought 5 million worth 30% above the then market price. They don't need cash they need a partnership which they will have no problem finding and are in discussions right now with several Big Pharmas. Drugs like this don't go unnoticed long with Big pharma sniffing around. Just sell and get lost because your comments are useless to the investing community
👍️0
runncoach runncoach 3 days ago
Was wondering about the pump.

Folks will soon learn you don't get billion dollar partnerships when the CEO is having to buy stock to keep the lights on I'm afraid. Give me 3 bucks and I'll sit this one out for a while.
👍️0
johnhancoque johnhancoque 3 days ago
$7.50 Cantor price target 🥱👀
👍️0
runncoach runncoach 3 days ago
Not immediately it won't, no. Not in a price sustainable way that is. I own shares but will sell any significant spikes and buy back lower to hold long term
👍️0
johnhancoque johnhancoque 4 days ago
You don't understand. A partnership with BP takes NRSN to the next level no looking back. Once a partnership is announced with a large upfront payment, there will be no looking back for this company, ever. It will be bought by BIg Pharma long before p3 results. Easy to manufacture and worldwide protection until 2044
👍️0
runncoach runncoach 4 days ago
The problem is there is a large number of warrant shares available that will keep a lid on the share price after any spikes. Company has low funds considering it has yet to begin their P3. Sales are 2-3 years away at the least. Details of any partnership will be very important concerning future potential money raises. Sell significant spikes is my advice because folks sitting on warrants likely will. JMHO
👍️0
johnhancoque johnhancoque 4 days ago
$9.25 price target. Partnership news looks imminent. Only 25 million market cap has 400% to run at a minimum here
👍️0
johnhancoque johnhancoque 4 days ago
CEO bought 5 million worth and no matter how you spin that it will always be a boon for the company and shareholders. Regardless of what you say, any ceo who puts up 5 million bucks and above market for that matter says everything about where the sp is headed nearterm and speaks volumes about the confidence he has in his company and the data. Simple as that!
👍️0
McMagyar McMagyar 4 days ago
Except
The value would have already rocketed well past $1.25.. with so few shares out.. and after the news hit, the company could have raised the same amount of money by issuing fewer shares, less dilution, shares more valuable.. now only one shareholder benefits from knowing the good news.. sure looks like a shareholder lawsuit to me.. greed sucks.. maybe the other shareholders will let it go.. maybe they won't..
You can't control what happens, but you can control with whom you do bizness..
Thx Barrister.. wise words
👍️0
johnhancoque johnhancoque 5 days ago
All that matters is he bought 5 million shares @ $1.25 and the share price is about to rocket hard. Analysts price targets north of $12.00
👍️0
McMagyar McMagyar 5 days ago
This smells a lot like stealing to me..
All the other shareholders got diluted.. while the sole stock buyer of issuance becomes kazillionairre.. sounds like an attorney would want to know what the shareholder who bought all this stock knew.. and why the offering wasn't made to other shareholders?
👍️0
johnhancoque johnhancoque 6 days ago
Insider trading doesn't mean insiders can't buy shares or participate in offerings. There are however windows they have to abide by and if a significant partnership is announced in January they are well within their time to buy shares
👍️0
johnhancoque johnhancoque 6 days ago
Insider trading doesn't mean insiders can't buy shares or participate in offerings. There are however windows they have to abide by and if a significant partnership is announced in January they are well within their time to buy shares
👍️0
runncoach runncoach 6 days ago
That would look quite a bit like inside trading if they did that the next couple months. Trust me I hope so but doesn't look good to me.
👍️0
johnhancoque johnhancoque 7 days ago
$25.00 with partnership and large upfront payment
👍️0
johnhancoque johnhancoque 7 days ago
Um....he sold himself the last offering because there is a multi Billion dollar partnership about to be signed
👍 1
McMagyar McMagyar 3 weeks ago
It was a money raise to one guy.. total bullshit. Thief
👍️0
runncoach runncoach 3 weeks ago
The issue to me is the stock was sold down the last 2 or 3 weeks on "no news" and then we get a low price money raise. Doesn't look good
👍️0
McMagyar McMagyar 3 weeks ago
Co issues 12,000,000 share rights to one guy right before good news hits?  What a legal Scally wag.. what's to stop him from issuing himself another 10,000,000?  Know them but their greed.
What a crock
👍️0
runncoach runncoach 3 weeks ago
Today's PR would certainly lead one to believe no partnership type of completion until next year at the earliest IMO
👍️0
runncoach runncoach 3 weeks ago
Just under 21 million
👍️0
BurgerKing82 BurgerKing82 3 weeks ago
What's OS now?
👍️0
runncoach runncoach 4 months ago
From this evening's 6K. No idea if it's BS or not.
NeuroSense Therapeutics Ltd. (the Company) hereby reports that it is currently in advanced discussions with several multi-billion-dollar pharmaceutical companies regarding a potential strategic partnership for the development and commercialization of its lead drug candidate, PrimeC, for the treatment of Amyotrophic Lateral Sclerosis (ALS).



These discussions, based on non-binding terms, indicate the potential for substantial financial benefits to NeuroSense, including upfront payments, milestone payments and royalty payments as part of an agreement. NeuroSense anticipates receiving terms from these discussions in Q4 2024; however, there can be no assurance that terms will be finalized with any of the pharmaceutical companies, the timing, what would be the final terms, if any, or that a definitive agreement will be reached.
👍️0
runncoach runncoach 4 months ago
Money raise with .75 warrants attached fyi. Now we know why the price has remained so low IMO
👍️0
vein vein 5 months ago
Thanks much for the insight !
👍️0
runncoach runncoach 5 months ago
Who knows? Unless you are trading the stock, real results are a long ways off IMO and that can lead to opportunity cost. If it's a small percentage of a speculative portfolio the current price probably isn't bad. Just depends on your patience level
👍️0
vein vein 5 months ago
Why the sell off ?? Thanks in advance!
👍️0
vein vein 5 months ago
Seems like a decent entry ?
👍️0
runncoach runncoach 5 months ago
The data is good but they'll have to raise money for a P3 so these guys are still a ways off IMO. They've mentioned a potential Biogen partnership last year yet here we stand. I do believe the drug is safe and has a real chance. Timing is everything.
👍️0
vein vein 5 months ago
Time to buy now ??? Newbie here! Any thoughts ??
👍️0
Monksdream Monksdream 6 months ago
NRSN under $2
👍️0
runncoach runncoach 6 months ago
Great data out. On to P3. Only thing that will likely sustain share price after this rally is partnership IMO.
👍️0
Awl416 Awl416 6 months ago
Don’t blink
👍️0
runncoach runncoach 8 months ago
Certainly showing a positive trend on the scientific front.
https://ih.advfn.com/stock-market/NASDAQ/neurosense-therapeutics-NRSN/stock-news/93791685/neurosense-announces-new-positive-data-analysis-fr
👍️0
runncoach runncoach 8 months ago
Financing broke the stock for now. Either Biogen news or dead money IMO
👍️0
runncoach runncoach 8 months ago
Looks like there will be a data presentation on the sixteenth at a conference. Back in for a gamble at 1.70.
👍️0
runncoach runncoach 8 months ago
And there's the money raise at 1.50
👍️0
runncoach runncoach 9 months ago
Sold at 2.12. Only update today on the additional biomarker data was talking about peer reviews and conferences. I expected data at least a month ago. I'm concerned they'll raise money before we get any significant data updates. I could be making a mistake but taking profits from .79 so can't be too upset if I do. I'll buy back if it goes lower most likely. GLTA
👍️0
glenn1919 glenn1919 9 months ago
NRSN..........................https://stockcharts.com/h-sc/ui?s=NRSN&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 9 months ago
NRSN under $2
👍️0
runncoach runncoach 9 months ago
I like Coya a lot as well. I was hoping to see how the Biogen data plays out here and then moving funds there. Hopefully I'll get that chance. I'm not sure COYA's next coming data will be ideal based on the dosage and other trial parameters but could give a great indication to set up a pivotal P3. Lot of bigger money over there. I've got my eyes on them for sure. JMHO
👍️0
FooBarAndGrill FooBarAndGrill 9 months ago
Suggest a look at $COYA for ALS.
👍️0
runncoach runncoach 10 months ago
Disappointed for the ALS community. Hoping NRSN can provide some hope.
https://finance.yahoo.com/news/amylyx-pharmaceuticals-announces-topline-results-120000695.html?guccounter=1&guce_referrer=YW5kcm9pZC1hcHA6Ly9jb20uZ29vZ2xlLmFuZHJvaWQuZ29vZ2xlcXVpY2tzZWFyY2hib3gv&guce_referrer_sig=AQAAAAM8h3Ee_7hkwe__ixrWmntWVPdxe8WZ1ZpxVn7ZSc5Y_cvU8dUOeH8gNnkII0GDb_rsadt-ieRtojdTcEbDoBluMPdmwoVEaO7k8HMPi6OgMQhLipitwShkj668qEiwBreTeVNkxishXrsTPgOOOMTmvMybqLk3QVA9AiTxt2Bt
👍️0

Your Recent History

NASDAQ
NRSN
NeuroSense Therapeutics
LSE
0Z1W
Kkr &
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads